Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation

American Journal of Transplantation

Volumn 2, Issue 2, 2002, Pages 134-141

  Pelletier, Ronald P ^a   Hennessy, Patrice K ^b   Adams, Patrick W ^b   VanBuskirk, Anne M ^a,c   Ferguson, Ronald M ^a,b   Orosz, Charles G ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Acute rejection; Alloantibodies; Chronic rejection; Transplantation

Indexed keywords

ALLOANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PANCREAS TRANSPLANTATION; RECIPIENT; RISK FACTOR;

EID: 0036487918     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.020204.x     Document Type: Article

References (20)

1. Ferguson R. Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328-331.
2. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson N. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 315-331.
3. Kokado Y, Takahara S, Hatori M et al. Acute rejection episodes predict long-term renal transplantation survival. Hum Immunol 1997; 29: 1537-1540.
4. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857-859.
5. Jin D, Yoon Y, Kim Y et al. Factors on graft survival of living donor kidney transplantation in a single center. Clin Transplant 1996; 10: 471-477.
6. Cole E, Naimark D, Aprile M et al. An analysis of predictors of longterm cadaveric renal allograft survival. Clin Transplant 1995; 9: 282-288.
7. Almond PS, Matas A, Gillingham K et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752-757.
8. Scornik JC, Salomon DR, Lim PB, Howard RJ, Pfaff WW. Posttransplant antidonor antibodies and graft rejection. Transplantation 1989; 47: 287-290.
9. Halloran PF, Schlaut J, Solez K, Srinivasa NS. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53: 550-555.
10. al-Hussein KA, Shenton BK, Bell A et al. Characterization of donor-directed antibody class in the post-transplant period using flow cytometry in renal transplantation. Transplant Int 1994; 7: 182-189.
11. Piazza A, Adorno D, Poggi E et al. Flow cytometry crossmatch. A sensitive technique for assessment of acute rejection in renal transplantation. Transplant Proc 1998; 30: 1769-1771.
12. Christiaans MHL, Overhof-De Roos R, Nieman F, Van Hooff JP, Van Den Berg-Loonen E. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival. Transplantation 1998; 65: 427-433.
13. Suciu-Foca N, Reed E, D'Agati VD et al. Soluble HLA antigens, anti-HLA antibodies, and antiidiotypic antibodies in the circulation of renal transplant recipients. Transplantation 1991; 51: 593-601.
14. Abe M, Kawai T, Futatsuyama K et al. Postoperative production of antidonor antibody and chronic rejection in renal transplantation. Transplantation 1997; 63: 1616-1619.
15. Martin S, Dyer PA, Mallick NP, Gokal R, Harris R, Johnson RG. Posttransplant antidonor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 50-53.
16. McKenna RM, Takemoto SK, Terasak PI.. Anti HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326.
17. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran P. Pathologic features of acute renal allograft rejection associated with donor-specific antibody: analysis using the Banff grading schema. Transplantation 1996; 61: 1586-1592.
18. Schonemann C, Groth J, Leverenz SG, May G. HLA ClassI and Class II antibodies. Monitoring before and after kidney transplantation and their clinical relevance. Transplantation 1998; 65: 1519-1523.
19. Muller-Steinhardt M, Fricke L, Kirchner H, Hoyer J, Kluter H. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation. Clin Transplant 2000; 14: 85-89.
20. Orosz C, Bergese SD, Wakely E, Xia D, Gordillo GM, VanBuskirk AM. Acute versus chronic graft rejection: Related manifestations of allosensitization in graft recipients. Transplant Rev 1997; 11: 38-50.